Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Lahousen, M; Haas, J.
Adjuvant chemotherapy in radical surgery of cervix cancer
ZBL GYNAKOL. 1990; 112(11): 707-713.
Web of Science PubMed

 

Autor/innen der Med Uni Graz:
Haas Josef
Lahousen Manfred
Altmetrics:

Dimensions Citations:

Plum Analytics:
Abstract:
Invasive cervical cancer can be treated by surgery, radiotherapy, and cytostatic chemotherapy. For decades, surgery alone or in combination with radiotherapy has been the treatment of choice. Radiotherapy only was reserved for patients with advanced disease. Antineoplastic agents, especially combinations including cisplatin, achieved good results in patients with advanced disease of after other therapeutic modalities had been exhausted. This led us to use postoperative chemotherapy for high-risk patients with positive pelvic or parametrial nodes or vascular invasion. Radiotherapy had not improved the survival of such patients. A combination of bleomycin, vincristine, mitomycin-C and cisplatin and later a combination of carboplatin and bleomycin was used. The results were compared to those of patients with radical abdominal surgery only (N = 118) or with surgery and postoperative radiotherapy (N = 108). The 32 patients who underwent surgery and chemotherapy had statistically higher incidence of all risk factors. Nonetheless, after 4-year follow-up they had less recurrences and deaths than the other patients.
Find related publications in this database (using NLM MeSH Indexing)
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Combined Modality Therapy -
Female -
Follow-Up Studies -
Humans -
Lymphatic Metastasis -
Radiotherapy Dosage -
Survival Rate -
Uterine Cervical Neoplasms - drug therapy Uterine Cervical Neoplasms - mortality Uterine Cervical Neoplasms - radiotherapy Uterine Cervical Neoplasms - surgery

© Meduni Graz Impressum